Introduction:

the coronavirus disease 2019 in children does not present a high casuistry globally and it is characterized by presenting a wide clinical spectrum. The evolution of the disease is less severe in kids than in adults according to the data which was provided by some studies in China and other countries.

Objective:

to describe the clinical aspects, the laboratory one and the treatment of COVID-19 in the pediatric population that was treated.

Methods:

a descriptive cross-sectional study from Villa Clara Province was carried out in 43 patients that were diagnosed with COVID-19 from March to October 2020, the group of people was selected by non-probabilistic sampling.

Results:

a total of 43 children were affected, the older than 15 years had more predomination, 20 children had the disease asymptomatically and the rest presented mild symptoms. Cutaneous manifestations and mild respiratory symptoms were highlighted. 17 patients presented mild leukopenia in the laboratory tests at 72 hours, the pulmonary radiological pattern was normal except in 2 children. The treatment was applied to everybody according to the actual protocol (kaletra, chloroquine and interferon) and it showed excellent results.

Conclusions:

the clinical diagnosis favored to register a higher incidence of the disease in the patients older than 15 years, the asymptomatic cases predominated and the patients developed mild symptoms of the disease, the majority presented normal laboratory values and chest X-rays, the treatment was based on triple therapy according to the Cuban action protocol at that time.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )